MAPK8 and colitis: Taken together, these results demonstrate that EcNΔlpp::A5‐aTN alleviates colitis by inhibiting ROS/JNK/p38/Caspase‐8/Caspase‐3‐mediated apoptosis in intestinal epithelial cells, and its effect is superior to both infliximab and the control strain EcNΔlpp::A5.